Press Releases

Press Releases

Astellas Pharma today announced that the company's President and CEO Yoshihiko Hatanaka will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2016 in San Francisco, California. The presentation will take place at The Westin St. Francis at 3 p.m., with a question and answer session…

Press Releases

Rite Aid Corporation announced today that pharmacists across its nearly 4,600 locations chainwide are now utilizing Pharmacy Quality Solutions’ (PQS) EQuIPP, an information management platform that provides access to performance data across key patient care quality metrics, including those focused on medication adherence and appropriate medication use. Rite Aid is…

Press Releases

Tris Pharma, Inc. ("Tris") is pleased to announce that the U.S. Food and Drug Administration ("FDA") approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year. Prior to Tris' breakthrough ER chewable technology, extended-release tablets and capsules typically…

Press Releases

In Europe, medication non-adherence costs governments an estimated €125 billion and contributes to the premature deaths of nearly 200,000 Europeans a year. The main reason for not taking medication was simple forgetfulness which was cited by 71% of those surveyed; followed by lack of belief that the medication was needed…

Press Releases

The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking drugs that cause temporary paralysis by interfering…

Press Releases

Amgen today announced that its Board of Directors declared a $1.00 per share dividend for the first quarter of 2016. The dividend will be paid on March 8, 2016, to all stockholders of record as of the close of business on Feb. 16, 2016. This represents a 27 percent increase…

Press Releases

CardioPharma, Inc., a pioneer in the development of cardiovascular fixed dose combination products, recently completed its FDA submission batch manufacturing for its lead compound, CP-101, a single capsule combining the gold standards of cardiovascular medicine:  an antihypertensive, a cholesterol modifying product and an anti-platelet agent. The company intends to begin…

Press Releases

Antares Pharma, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for 4 mg/0.5 mL and 6 mg/0.5 mL Sumatriptan Injection USP in adults for the acute treatment of migraine and cluster headache when a clear diagnosis has been established. The…

Press Releases

The board of directors of Pfizer Inc. today declared a 30-cent first-quarter 2016 dividend on the company’s common stock, payable March 2, 2016, to shareholders of record at the close of business on February 5, 2016. Pfizer increased the dividend by approximately 7 percent, to 30 cents from 28 cents…

Press Releases

Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. today announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of genomic applications…